chr20-34928738-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000178.4(GSS):​c.*90A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,445,878 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 8 hom., cov: 31)
Exomes 𝑓: 0.00073 ( 8 hom. )

Consequence

GSS
NM_000178.4 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.643

Publications

2 publications found
Variant links:
Genes affected
GSS (HGNC:4624): (glutathione synthetase) Glutathione is important for a variety of biological functions, including protection of cells from oxidative damage by free radicals, detoxification of xenobiotics, and membrane transport. The protein encoded by this gene functions as a homodimer to catalyze the second step of glutathione biosynthesis, which is the ATP-dependent conversion of gamma-L-glutamyl-L-cysteine to glutathione. Defects in this gene are a cause of glutathione synthetase deficiency. [provided by RefSeq, Jul 2008]
GSS Gene-Disease associations (from GenCC):
  • inherited glutathione synthetase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • glutathione synthetase deficiency with 5-oxoprolinuria
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 20-34928738-T-C is Benign according to our data. Variant chr20-34928738-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 338290.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00514 (782/152026) while in subpopulation AFR AF = 0.018 (746/41438). AF 95% confidence interval is 0.0169. There are 8 homozygotes in GnomAd4. There are 372 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GSSNM_000178.4 linkc.*90A>G 3_prime_UTR_variant Exon 13 of 13 ENST00000651619.1 NP_000169.1 P48637-1V9HWJ1
GSSNM_001322494.1 linkc.*90A>G 3_prime_UTR_variant Exon 13 of 13 NP_001309423.1 P48637-1V9HWJ1
GSSNM_001322495.1 linkc.*90A>G 3_prime_UTR_variant Exon 13 of 13 NP_001309424.1 P48637-1V9HWJ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GSSENST00000651619.1 linkc.*90A>G 3_prime_UTR_variant Exon 13 of 13 NM_000178.4 ENSP00000498303.1 P48637-1

Frequencies

GnomAD3 genomes
AF:
0.00514
AC:
781
AN:
151908
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0180
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.000957
GnomAD4 exome
AF:
0.000729
AC:
943
AN:
1293852
Hom.:
8
Cov.:
19
AF XY:
0.000612
AC XY:
398
AN XY:
650448
show subpopulations
African (AFR)
AF:
0.0184
AC:
555
AN:
30218
American (AMR)
AF:
0.000642
AC:
27
AN:
42058
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24802
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38374
South Asian (SAS)
AF:
0.0000246
AC:
2
AN:
81268
European-Finnish (FIN)
AF:
0.000134
AC:
7
AN:
52388
Middle Eastern (MID)
AF:
0.000186
AC:
1
AN:
5382
European-Non Finnish (NFE)
AF:
0.000312
AC:
301
AN:
964592
Other (OTH)
AF:
0.000913
AC:
50
AN:
54770
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00514
AC:
782
AN:
152026
Hom.:
8
Cov.:
31
AF XY:
0.00501
AC XY:
372
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.0180
AC:
746
AN:
41438
American (AMR)
AF:
0.00157
AC:
24
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67974
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00147
Hom.:
1
Bravo
AF:
0.00563
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Inherited glutathione synthetase deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.71
DANN
Benign
0.55
PhyloP100
-0.64
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35747685; hg19: chr20-33516541; API